Assignee
FABRE KRAMER PHARMACEUTICALS I
US·1 granted patent·5 pending applications·3 citations·filing 2000–2009
Top patents by PatentIndex Score
6 records- 0158US6534507B1Methods for treating psychological disorders using bioactive metabolites of gepironeFABRE KRAMER PHARMACEUTICALS I·Filed 2000·Granted Mar 18, 2003·3 cites·40 claims
- 0249US2009281112A1Adatanserin and metabolites thereof for treatment of attention deficit disorder, anxiety, depression, sexual dysfunction, and other disordersFABRE KRAMER PHARMACEUTICALS I·Filed 2009·Application pending·0 cites
- 0343US2006099267A1High-dosage extended-release formulation of gepironeFABRE KRAMER PHARMACEUTICALS I·Filed 2004·Application pending·0 cites
- 0442US2005095286A1Extended release compositionsFABRE KRAMER PHARMACEUTICALS I·Filed 2004·Application pending·0 cites
- 0538US2009281111A13-hydroxy gepirone for the treatment of attention deficit disorder and sexual dysfunctionFABRE KRAMER PHARMACEUTICALS I·Filed 2009·Application pending·0 cites
- 0638US2009281114A1Indolylalkyl derivatives of pyrimidinylpiperazine and metabolites thereof for treatment of anxiety, depression, and sexual dysfunctionFABRE KRAMER PHARMACEUTICALS I·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when FABRE KRAMER PHARMACEUTICALS I files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →